Ian Reginald Reid

This inventor holds 10 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Auckland Uniservices Limited, Fonterra Corporate Research and Development Ltd., Nzmp + Health and Nutrition Unit. Active years: 1999-2014.

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 40.0

EPO Patents = 2

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 36(Granted Patents)

Location History:

Mt. Albert, NZ (1999 - 2008)
Auckland, NZ (1999 - 2014)

Company Filing History:

10 out of 253

Auckland Uniservices Limited

patents

1 out of 1

Fonterra Corporate Research and Development Ltd.

patent

1 out of 1

Nzmp + Health and Nutrition Unit

patent

4. 1 out of 248

The Administrators of the Tulane Educational Fund

patents

where one patent can have more than one assignee

Years Active: 1999-2014

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8703699 - Lactoferrin (2014-04-22),

2. 7414019 - FGF-8 methods of use (2008-08-19),

3. 7314856 - Adrenomedullin agonists (2008-01-01),

4. 7208469 - Therapeutic method (2007-04-24),

5. 7169559 - LDL receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions (2007-01-30),

6. 6869926 - Therapeutic method (2005-03-22),

7. 6821954 - Compounds and uses thereof in treating bone disorders (2004-11-23),

8. 6440421 - Treatment of bone disorders with adrenomedullin or adrenomedullin agonists (2002-08-27),

9. 5922677 - Therapeutic method and compounds of use therein (1999-07-13),

10. 5888963 - Treatment of bone disorders with adrenomedullin (1999-03-30),

Title: The Innovations of Ian Reginald Reid

Introduction

Ian Reginald Reid is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of biomedical research, particularly in the area of bone health. With a total of 10 patents to his name, Reid's work has the potential to impact various medical treatments and improve patient outcomes.

Latest Patents

One of Reid's latest patents is for a pure lactoferrin polypeptide that contains no more than two metal ions per molecule. This polypeptide or a mixture of it and a fragment stimulates skeletal growth and inhibits bone resorption. Additionally, he has developed a method for treating bone-related disorders using this polypeptide or mixture. Another significant invention is related to FGF-8, which features a method for treating bone conditions in various mammals, including humans, horses, dogs, and cats. This method involves administering an effective amount of FGF-8, FGF-8 analog, or a FGF-8 agonist to the patient.

Career Highlights

Throughout his career, Ian Reid has worked with prominent organizations such as Auckland Uniservices Limited and Fonterra Corporate Research and Development Ltd. His work in these companies has allowed him to further his research and develop innovative solutions in the field of bone health.

Collaborations

Reid has collaborated with several professionals in his field, including Jillian Cornish and Garth James Smith Cooper. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Ian Reginald Reid's contributions to biomedical research, particularly in bone health, are noteworthy. His innovative patents and collaborations highlight his commitment to improving medical treatments and patient care.